Recruiting Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors NCT05269381 Conditions Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +165 more Locations Mayo Clinic in Florida — Jacksonville, Florida, United States View Trial Details
Not Yet Recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial NCT07576725 Conditions Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more Locations Uganda Cancer Institute — Kampala, Uganda View Trial Details
